Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical Trial-Reference-Cited by-同舟云学术

Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical Trial

Published:2022-05-15 Issue:10 Volume:205 Page:1228-1235
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

De Jager Veronique¹^ORCID,Gupte Nikhil²³,Nunes Silvia¹,Barnes Grace L.²,van Wijk Rob Christiaan⁴^ORCID,Mostert Joni¹,Dorman Susan E.⁵,Abulfathi Ahmed A.⁶⁷,Upton Caryn M.¹,Faraj Alan⁴,Nuermberger Eric L.²,Lamichhane Gyanu²,Svensson Elin M.⁸⁹^ORCID,Simonsson Ulrika S. H.⁴^ORCID,Diacon Andreas H.¹,Dooley Kelly E.²^ORCID

Affiliation:

1. TASK Applied Science, Cape Town, South Africa;

2. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland;

3. Johns Hopkins India, Pune, India;

4. Department of Pharmaceutical Biosciences and

5. Medical University of South Carolina, Charleston, South Carolina;

6. Department of Medicine, Stellenbosch University, Cape Town, South Africa;

7. Department of Clinical Pharmacology and Therapeutics, University of Maiduguri, Maiduguri, Nigeria; and

8. Department of Pharmacy, Uppsala University, Uppsala, Sweden;

9. Department of Pharmacy, Radboud University, Njimegen, the Netherlands

Funder

Vetenskapsrådet